- Product Details
Keywords
- 298-57-7 Stugeron
- cinnarizine exporter
- Cinnarazine
Quick Details
- ProName: cinnarizine(Stugeron)
- CasNo: 298-57-7
- Molecular Formula: C26H28N2
- Appearance: white or almost white powder
- Application: Cinnarizine is used to treat problems ...
- DeliveryTime: within 7 days after order confirmation
- PackAge: according to customer requirement
- Port: Shanghai, Qingdao, Tianjin, Ningbo, Xi...
- ProductionCapacity: 500 Kilogram/Month
- Purity: 99.6%
- Storage: protected from light
- Transportation: By air, by sea, by express
- LimitNum: 10 Gram
- Residue on Ignition: Maximum 0.1%
- Heavy Metal: Maximum 20 ppm
- Valid Period: 2 years
- Impurity A: not more than 0.25%
- Impurity B: not more than 0.25%
- Impurity C: not more than 0.25%
- Impurity D: not more than 0.25%
- Impurity E: not more than 0.25%
- Total impurities: not more than 0.5%
- Disregard limi: not more than 0.05%
- Melting point: 118℃ to 122 ℃
Superiority
XI'AN VEDA CHEMICAL CO.,LTD, is specializes in APIs and Intermediates products.
Cinnarizine is one of the featured products.
Cinnarizine helps reduce the feelings of sickness and vertigo caused by problems
such as these. It is available on prescription, or you can buy it without a
prescription at a pharmacy. It can be taken by adults and by children over the age
of 5 years.
Our superiority:
1) Responding quickly
2) Product quality control strictly
3) Excellent service
4) Mutual benefitial business
Details
product Name |
cinnarizine |
Synonyms |
1-benzhydryl-4-trans-cinnamylpiperazine; Cinnarazine; 1-(diphenylmethyl)-4-[(1E)-3-phenylprop-1-en-1-yl]piperazine; Stugeron |
Molecular Formula |
C26H28N2 |
Molecular Weight |
368.5139 |
InChI |
InChI=1/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-12,14-18,26H,13,19-22H2/b18-10+ |
CAS Registry Number |
298-57-7 |
EINECS |
206-064-8 |
Molecular Structure |
|
Density |
1.125g/cm3 |
Boiling point |
505.8 deg C at 760 mmHg |
Refractive index |
1.649 |
Flash point |
228.1 deg C |
Vapour Pressure |
2.35E-10mmHg at 25 deg C |
Content |
99%~101.0% |
|
Appearance |
White or almost white powder |
|
Solubility |
Practically insoluble in water, freely soluble in methylene chloride, soluble in acetone, slightly soluble in ethanol(96 percent) and in methanol |
|
Identification |
melting point |
118℃ to 122 ℃ |
IR |
Correspond with CRS |
|
Acidity or alkalinity |
The solution is red |
|
Related substances |
Impurity A: not more than 0.25% |
|
Impurity B: not more than 0.25% |
||
Impurity C: not more than 0.25% |
||
Impurity D: not more than 0.25% |
||
Impurity E: not more than 0.25% |
||
|
Total impurities: Not more than 0.5% |
|
|
Disregard limit: not more than 0.05% |
|
Heavy metals |
Maximum 20 ppm |
|
Loss on drying |
Maximum 0.5% |
|
Sulphated ash |
Maximum 0.1% |
Cinnarizine is used to treat problems affecting the inner ear and balance, such as dizziness and sickness. It is also helpful in preventing travel sickness.
Nerves situated inside your ear send messages to your brain with information about your movement. Along with messages from your eyes and muscles, these nerves help your body to maintain a good sense of balance. If the nerves in one of your ears send too many, too few, or wrong messages to your brain, it conflicts with the messages sent from your other ear, your eyes, or your body. Your brain then gets confused and this can cause dizziness and a spinning sensation (vertigo), and can make you feel sick.
Travel sickness is caused by repeated unusual movements during travelling. These repeated movements, such as going over bumps or around in a circle, send lots of messages to your brain. The balance mechanism in your ear sends different signals to those from your eyes, which results in your brain receiving mixed and confusing messages. This is what causes you to feel sick.
Cinnarizine helps reduce the feelings of sickness and vertigo caused by problems such as these. It is available on prescription, or you can buy it without a prescription at a pharmacy. It can be taken by adults and by children over the age of 5 years.